Susquehanna Maintains Positive on MaxLinear, Lowers Price Target to $22
Portfolio Pulse from Benzinga Newsdesk
Susquehanna analyst Christopher Rolland maintains a positive outlook on MaxLinear (NASDAQ:MXL), but has lowered the price target from $30 to $22.
October 26, 2023 | 2:20 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Susquehanna analyst has maintained a positive outlook on MaxLinear but lowered the price target from $30 to $22.
The news directly pertains to MaxLinear. While the positive outlook is maintained, the lowering of the price target could indicate potential concerns about the company's future performance. This could have a neutral impact on the stock price in the short term as the positive and negative sentiments balance each other out.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100